N. De Stefano et al., Magnetic resonance imaging and spectroscopic changes in brains of patientswith cerebrotendinous xanthomatosis, BRAIN, 124, 2001, pp. 121-131
Cerebrotendinous xanthomatosis (CTX) is a rare disorder due to an inherited
defect in the metabolic pathway of cholesterol, Early diagnosis of the dis
ease is particularly important as patients benefit from therapy with chenod
eoxycholic acid. Although the disease is clinically characterized by the co
ncomitant presence of tendon xanthomas, juvenile cataracts and progressive
neurological impairment, clinical features may vary greatly. Neuroradiologi
cal studies have suggested that the bilateral abnormality of the dentate nu
clei could be typical of this disease. However, this finding has been seen
inconsistently on conventional MRT, The dynamic of the CNS pathology in CTX
is complex, and whether demyelination or axonopathy has primary importance
in the pathogenesis of CTX pathology is not known. To clarify both neurora
diological and pathological issues, we performed combined brain MRI and spe
ctroscopy examinations on 12 CTX patients. On conventional MRIs, bilateral
hyperintensities of the dentate nuclei were clearly seen in nine out of 12
patients on T-2-weighted MRIs, but were evident in all patients using a FLA
IR sequence. On proton magnetic resonance (MR) spectroscopy, significant de
creases in N-acetylaspartate resonance intensities (P < 0.0001) and increas
es in lactate MR signals (P < 0.05) were found in the group of CTX patients
in large volumes of interest localized above the lateral brain ventricles
and in the cerebellar hemispheres. Cerebral values of N-acetylaspartate res
onance intensities showed a close correlation with patients' disability (Sp
earman rank correlation = -0.78, P < 0.005). These results suggest that MR
abnormalities in the dentate nuclei may be evident consistently in patients
with CTX. Proton MR spectroscopy data demonstrated widespread axonal damag
e las shown by the decrease in N-acetylaspartate) and diffuse brain mitocho
ndrial dysfunction las shown by the increase in brain parenchymal lactate)
in patients with CTX. The close correlation seen between values of the puta
tive axonal marker N-acetylaspartate and patients' disability scores sugges
ts that proton MR spectroscopy can provide a useful measure of disease outc
ome in CTX.